MedWatch

Novo Holdings CEO satisfied with little return: "I'm not planning to act on it"

Danish investment firm Novo Holdings, the owner of Novo Nordisk and Novozymes, earned 17 percentage point less return in 2018. However, the result still beats that of other large investment funds and the CEO is satisfied.

Foto: Ritzau Scanpix/Niels Ahlmann Olesen

2018 only brought one percent return on the investment portfolio, relative to 18 percent in 2017, for Novo Holdings - the company behind Novo Nordisk, Novozymes, Novo Seeds and Novo Ventures. However, it does not affect CEO Kasim Kutay.

"Although the total return was disappointing, we are relatively satisfied when we compare ourselves to other investment firms and funds," he says to MedWatch.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier